OrphanDrug
OrphanDrug
Pharma Knowledge Base

malignant pleural mesothelioma

ORPHA: 50251

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

pleural cancer that has material basis in mesothelium cells

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with malignant pleural mesothelioma, sourced from HPO and Orphanet clinical annotations.

Pleural effusionAbnormal thorax morphologyWeight lossDyspneaRespiratory distressAbnormal pleura morphologyCoughConstitutional symptomChest painDysphagiaAbnormal lung morphologyHepatomegalyLymphadenopathyAbnormal respiratory system physiologyFourth cranial nerve palsyAbnormal cardiovascular system physiologyObstruction of the superior vena cava

Classification & Codes

Orphanet Code

ORPHA:50251
malignant pleural mesothelioma
OrphanetORPHA:50251
Treatments0 drug(s)
Symptoms on record17 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO